A Study to Investigate Effects of Ocrelizumab Treatment on Neurofilament Light Chain (NfL) Levels and Participant Satisfaction in Participants With Multiple Sclerosis (MS)

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
The main purpose of the study is to evaluate participant satisfaction after administration of ocrelizumab subcutaneous (SC) after 12 months using the therapy administration satisfaction questionnaire subcutaneous (TASQ-SC).
Epistemonikos ID: ab367ae3b4db64c48965199eb4acc662fcba245d
First added on: Feb 01, 2025